This site became the new on June 19th. Learn more.
Show more Menu IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. Read more... Menu IMPORTANT: Talk with a trusted healthcare professional before volunteering for a study. Read more... Menu
Give us feedback

Time Course of Procalcitonin and C Reactive Protein in Septic Patients Under Treatment With Corticosteroids

This study has been completed.
Brahms SA, D-16761 Hennigsdorf bei Berlin
Information provided by:
Ospedale Regionale Bellinzona e Valli Identifier:
First received: September 1, 2005
Last updated: May 13, 2008
Last verified: May 2008

A systemic treatment with corticosteroids has been advocated for various bacterial infectious diseases. Since the production of CRP is down-regulated by corticosteroids, a smaller increase or a more rapid decrease of this acute phase protein will:

  1. suggest attenuated systemic inflammation, but
  2. does not necessarily reflect adequate therapy of the infection.

For several reasons (good diagnostic tool for sepsis, induction not decreased by immunosuppressive therapy), procalcitonin could be a better marker for activity of sepsis in patients under corticosteroids. As this issue has not yet been examined the investigators will prospectively study the time-course of PTC and CRP in a well-defined septic patient group, that in adjunction to antibiotic therapy also received systemic corticosteroid treatment and compare it to a similar group without corticosteroid treatment.


Study Type: Observational
Study Design: Time Perspective: Prospective

Resource links provided by NLM:

Further study details as provided by Ospedale Regionale Bellinzona e Valli:

Study Start Date: November 2004
Estimated Study Completion Date: December 2005

Ages Eligible for Study:   50 Years to 80 Years   (Adult, Senior)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No

Inclusion Criteria:

  • Acute exacerbation of chronic obstructive pulmonary disease (COPD) due to bacterial pneumonia

Exclusion Criteria:

  • Chronic systemic use of corticosteroids
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its identifier: NCT00141973

Ospedale Regionale Bellinzona e Valli
Bellinzona, Ticino, Switzerland, 6500
Sponsors and Collaborators
Ospedale Regionale Bellinzona e Valli
Brahms SA, D-16761 Hennigsdorf bei Berlin
Principal Investigator: Andreas Perren, MD Ospedale Regionale Bellinzona e Valli, CH-6500 Bellinzona
  More Information Identifier: NCT00141973     History of Changes
Other Study ID Numbers: CE1408
Study First Received: September 1, 2005
Last Updated: May 13, 2008

Keywords provided by Ospedale Regionale Bellinzona e Valli:

Additional relevant MeSH terms:
Systemic Inflammatory Response Syndrome
Pathologic Processes processed this record on September 21, 2017